Clinical trial · Interventional
Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography
NCT06164392CI-TRIAL-00084280withdrawnPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): The attendings who were to participate did not want to alter their standard neuroma treatment of neurotomy and TMR, as opposed to dissecting the end of all neuromas before neurotomy. No patients were enrolled in the study.
Summary
Brief summary (as posted)
The purpose of this study is to characterize the perfusion of neuromas using indocyanine green fluorescence angiography
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neuroma | — | UNRESOLVED | — |
| Neuroma Amputation | — | UNRESOLVED | — |
| Neuroma of Lower Limb | — | UNRESOLVED | — |
| Neuroma of Upper Limb | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Indocyanine green | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Neuroma ICG
- description
- Subjects will receive Intravenous ICG to generate a Fluorescence Angiogram of the Neuroma
- interventionNames
- Drug: Indocyanine green
Primary outcomes (1)
- measure
- Neuroma ICG Fluorescence Angiogram
- timeFrame
- Intraoperative
- description
- Nerve Tissue Perfusion as visualized by Fluorescence Angiogram
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age \> 18 years * Clinical diagnosis of neuroma * Scheduled elective surgery for neuroma excision Exclusion Criteria: * Minors, or age \< 18 years old at the time of surgery * Unable to provide written, informed consent * Prisoners and decision-impaired individuals * Pregnant or lactating women * History of allergy to indocyanine green * History of allergy to iodides * History of allergic asthma * History of hepatic failure * History of renal failure * Patients in whom the planned surgical incision/approach does not include excision of the neuroma * Patients in whom adequate surgical exposure of the neuroma is unable to be obtained, as determined intraoperatively at the time of surgery by the Investigator or Co-Investigators * Any subject who, at the discretion of the Investigator or Co-Investigators, is not suitable for inclusion in the study
References
Publications (0)
Data not yet available
No reference posted for this study.